Tonix Pharmaceuticals
TNXP
#8662
Rank
NZ$0.34 B
Marketcap
NZ$21.73
Share price
-8.79%
Change (1 day)
-64.80%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2025 (TTM): -NZ$0.17 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are NZ$10.29 Million. In 2024 the company made an earning of -NZ$0.13 Billion, an increase over its 2023 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.17 Billion28.9%
2024 -NZ$0.13 Billion-36.5%
2023 -NZ$0.21 Billion5.61%
2022 -NZ$0.2 Billion21.43%
2021 -NZ$0.16 Billion82.76%
2020 -NZ$85.95 Million75.22%
2019 -NZ$49.06 Million9.52%
2018 -NZ$44.79 Million23.63%
2017 -NZ$36.23 Million-45.36%
2016 -NZ$66.31 Million-19.09%
2015 -NZ$81.95 Million74.15%
2014 -NZ$47.06 Million153.99%
2013 -NZ$18.53 Million
2011 -NZ$8.94 Million29538.74%
2010 -NZ$0.04 Million-42.58%
2009 -NZ$0.06 Million46.05%
2008 -NZ$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-NZ$39.55 Million-75.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
NZ$60.67 M-137.16%๐Ÿ‡บ๐Ÿ‡ธ USA